Parazzini F - Search Results

1

Paclitaxel 175 or 225 mg per meters squared with carboplatin in advanced ovarian cancer: a randomized trial.

Bolis G, Scarfone G, Polverino G, Raspagliesi F, Tateo S, Richiardi G, Melpignano M, Franchi M, Mangili G, Presti M, Villa A, Conta E, Guarnerio P, Cipriani S, Parazzini F. Bolis G, et al. Among authors: parazzini f. J Clin Oncol. 2004 Feb 15;22(4):686-90. doi: 10.1200/JCO.2004.03.017. J Clin Oncol. 2004. PMID: 14966092 Free article. Clinical Trial.

2

Side of origin of ovarian cancer.

Parazzini F, Luchini L, Vercellini P, Bolis G, Dindelli M. Parazzini F, et al. BMJ. 1992 May 2;304(6835):1180. doi: 10.1136/bmj.304.6835.1180-c. BMJ. 1992. PMID: 1392812 Free PMC article. No abstract available.

3

Risk factors for gestational trophoblastic disease: a separate analysis of complete and partial hydatidiform moles.

Parazzini F, Mangili G, La Vecchia C, Negri E, Bocciolone L, Fasoli M. Parazzini F, et al. Obstet Gynecol. 1991 Dec;78(6):1039-45. Obstet Gynecol. 1991. PMID: 1945204

4

Critical review of the quality and development of randomized clinical trials (RCTs) and their influence on the treatment of advanced epithelial ovarian cancer.

Marsoni S, Torri W, Taiana A, Gambino A, Grilli R, Liati P, Franzosi MG, Pistotti V, Parazzini F, Focarile F, et al. Marsoni S, et al. Among authors: parazzini f. Ann Oncol. 1990 Sep;1(5):343-50. doi: 10.1093/oxfordjournals.annonc.a057772. Ann Oncol. 1990. PMID: 2148106 Free article.

5

Dietary factors and risk of trophoblastic disease.

Parazzini F, La Vecchia C, Mangili G, Caminiti C, Negri E, Cecchetti G, Fasoli M. Parazzini F, et al. Am J Obstet Gynecol. 1988 Jan;158(1):93-9. doi: 10.1016/0002-9378(88)90785-5. Am J Obstet Gynecol. 1988. PMID: 2827487

6

The problem of identification of prognostic factors for persistent trophoblastic disease.

Parazzini F, Mangili G, Belloni C, La Vecchia C, Liati P, Marabini R. Parazzini F, et al. Gynecol Oncol. 1988 May;30(1):57-62. doi: 10.1016/0090-8258(88)90046-7. Gynecol Oncol. 1988. PMID: 2835296

7

Frequency of hydatidiform mole in Lombardy, Northern Italy.

Mazzanti P, La Vecchia C, Parazzini F, Bolis G. Mazzanti P, et al. Among authors: parazzini f. Gynecol Oncol. 1986 Jul;24(3):337-42. doi: 10.1016/0090-8258(86)90311-2. Gynecol Oncol. 1986. PMID: 3721306

8

Survival of advanced ovarian cancer patients with microscopic partial response after surgery and first-line chemotherapy.

Bolis G, Villa A, Ferraris C, Luchini L, Parazzini F. Bolis G, et al. Among authors: parazzini f. Eur J Cancer. 1995 Jun;31A(6):1019-20. doi: 10.1016/0959-8049(95)00070-4. Eur J Cancer. 1995. PMID: 7646902 No abstract available.

9

Response to second-line weekly cisplatin chemotherapy in ovarian cancer previously treated with a cisplatin- or carboplatin-based regimen.

Bolis G, Scarfone G, Luchini L, Ferraris C, Zanaboni F, Presti M, Giardina G, Villa A, Parazzini F. Bolis G, et al. Among authors: parazzini f. Eur J Cancer. 1994;30A(12):1764-8. doi: 10.1016/0959-8049(94)e0125-n. Eur J Cancer. 1994. PMID: 7880602

10

Risk factors for benign ovarian teratomas.

Parazzini F, La Vecchia C, Negri E, Moroni S, Villa A. Parazzini F, et al. Br J Cancer. 1995 Mar;71(3):644-6. doi: 10.1038/bjc.1995.127. Br J Cancer. 1995. PMID: 7880752 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

692 results

Search Page